Author:
Springer Caroline J.,Niculescu-Duvaz Ion
Reference31 articles.
1. Black, M.E., Newcomb, T.G., et al., 1996, Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy, Proc. Natl. Acad. Sci., USA, 93:3525–3529.
2. Borelli, E., Heyman, R., et al., 1988, Targeting of an inducible toxic phenotype in animal cell., Proc. Natl. Acad. Sci., USA, 85:7572–7576.
3. Bridgewater, G., Springer, C.J., et al., 1995, Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954, Eur. J. Cancer, 31A:2362–2370.
4. Chen, L., and Waxman, D.J., 1995, Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: Development of a combined chemotherapy/cancer gene therapy strategy, Cancer Res., 55:581–589.
5. Culver, K.W., 1996, The role of herpes simplex thymidine kinase gene transfer in the drug treatment of brain tumors, CNS Drugs, 6:1–11.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献